SEC Form 4 · accession 0001209191-18-021949
Protagonist Therapeutics, Inc · PTGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dinesh V Ph D Patel
Officer — President and CEO · Director
Period of report
Mar 26, 2018
Accepted (ET)
Mar 28, 2018 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 26, 2018 | M | 11,298 | $0.87 | A | 232,263 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.87 | Mar 26, 2018 | M | 11,298 | D | — | Sep 26, 2023 | Common Stock | 11,298 | 0 | D |
Explanation of responses
- F1Includes 1,706 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2018.
- F2The option is fully vested.